Current clinical trials for the proteasome inhibitor PS-341

被引：0
|
作者：
不详
机构：
来源：
ONCOLOGY-NEW YORK | 2000年 / 14卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1589 / +
页数：5
相关论文
共 50 条
  • [1] Development of the proteasome inhibitor PS-341
    Adams, J
    [J]. ONCOLOGIST, 2002, 7 (01): : 9 - 16
  • [2] The proteasome inhibitor PS-341 in cancer therapy
    Teicher, BA
    Ara, G
    Herbst, R
    Palombella, VJ
    Adams, J
    [J]. CLINICAL CANCER RESEARCH, 1999, 5 (09) : 2638 - 2645
  • [3] Preclinical and clinical evaluation of proteasome inhibitor PS-341 for the treatment of cancer
    Adams, J
    [J]. CURRENT OPINION IN CHEMICAL BIOLOGY, 2002, 6 (04) : 493 - 500
  • [4] PS-341, a proteasome inhibitor for cancer treatment.
    Adams, J
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2001, 222 : U665 - U665
  • [5] The proteasome inhibitor, PS-341, causes cytokeratin aggresome formation
    Bardag-Gorce, F
    Riley, NE
    Nan, L
    Montgomery, RO
    Li, J
    French, BA
    Lue, YH
    French, SW
    [J]. EXPERIMENTAL AND MOLECULAR PATHOLOGY, 2004, 76 (01) : 9 - 16
  • [6] Proteasome inhibitor PS-341 and docetaxel: sequence of administration may be crucial
    Garfield, D
    [J]. LANCET ONCOLOGY, 2001, 2 (12): : 714 - 714
  • [7] Molecular mechanisms mediating antimyeloma activity of proteasome inhibitor PS-341
    Hideshima, T
    Mitsiades, C
    Akiyama, M
    Hayashi, T
    Chauhan, D
    Richardson, P
    Schlossman, R
    Podar, K
    Munshi, NC
    Mitsiades, N
    Anderson, KC
    [J]. BLOOD, 2003, 101 (04) : 1530 - 1534
  • [8] Investigative cardiovascular study of the proteasome inhibitor PS-341 in the mouse.
    Rottman, J
    Csizmadia, V
    Ozkaynak, E
    Kadambi, V
    Ganley, K
    Cardoza, K
    Juedes, M
    Bouchard, P
    [J]. TOXICOLOGICAL SCIENCES, 2003, 72 : 47 - 47
  • [9] Phase II clinical experience with the proteasome inhibitor PS-341 in patients with indolent lymphomas.
    O'Connor, OA
    Moskowitz, CH
    Wright, JJ
    MacGregor-Cortelli, B
    Straus, D
    Furst, D
    Horse-Grant, D
    Schenkein, DP
    Zelenetz, AD
    [J]. BLOOD, 2002, 100 (11) : 774A - 774A
  • [10] Proteasome inhibition in cancer: Development of PS-341
    Adams, J
    [J]. SEMINARS IN ONCOLOGY, 2001, 28 (06) : 613 - 619
12345